Glaxo Smith Kline (GSK) announced in May that Flovent HFA, a metered-dose inhaler, as well as Flovent Diskus, a dry powder inhaler, would be discontinued as of Dec. 31, 2023. Experts weigh in.

Flovent — a common asthma inhaler — will be discontinued in 2024. There will be a generic version available, but the change could make it hard for some patients to get their medication.

NH Health A top inhaler for children was discontinued. Families and doctors are scrambling to fill the gap. Some pediatricians say they’ve seen an increase in asthma-related hospitalizations and ...

When it comes to inhalers commonly used in the U.S., each puff has about the same climate impact as driving a gas-powered car one mile. But increasingly, there are alternative inhalers for some ...

Sen. Bernie Sanders and President Biden joined forces Wednesday at the White House, championing the progress they've made on lowering the cost of inhalers and other expenses for Americans with ...

Three years ago, the cigarette giant acquired Vectura, a British pharmaceutical firm that makes asthma inhalers, raising health groups’ ire. Now, it’s selling the business for almost $200 million.